Regencell Bioscience Holdings Ltd
RGC- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001829667
No open-market purchases or sales by Regencell Bioscience Holdings Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $8.56M in total; no superinvestor holds it.
Holders of 5% or more of RGC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Regencell Bioscience Holdings Ltd, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Regencell (BVI) Ltd | 13D/A | 88.60%437.9M shares | +2.40 ppfrom 86.20% | Jul 27, 20213 filings | Jul 11, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
3 Schedule 13D and 13G filings on Regencell Bioscience Holdings Ltd, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jul 11, 20254:15 PM ET | Regencell (BVI) Ltdand 1 other | 13D/A | 88.60%437.9M shares | +2.40 ppfrom 86.20% | Jul 11, 2025 | SEC |
| Mar 13, 20256:16 AM ET | Regencell (BVI) Ltdand 1 other | 13D/A | 86.20%11.2M shares | – | Mar 10, 2025 | SEC |
| Jul 27, 2021 | Regencell (BVI) Ltd | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Regencell Bioscience Holdings Ltd shares.
No Form 144 notices for Regencell Bioscience Holdings Ltd are on file.